Nyxoah S.A.

NASDAQ:NYXH

Medical - Instruments & Supplies

Healthcare
$0.86 +1.25%

+$0.02 today

Market cap
$87.45M
Beta
0.89
P/E (TTM)
-0.7
EPS (TTM)
-$1.99
52W Low $1.26High $8.59

Volume 0.09M

Average 0.22M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$67.50M

FY 2025 · Annual

Investing Cash Flow

$26.17M

FY 2025 · Annual

Financing Cash Flow

$38.79M

FY 2025 · Annual

-49.9% YoY

Cash Flow Statement

EUR
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(24.64M)(30.06M)(44.66M)(56.43M)(90.05M)
Depreciation & Amortization1.66M1.93M2.36M2.72M4.48M
Deferred Income Tax00000
Stock-Based Compensation1.27M2.7M2.61M3.97M0
Change in Working Capital(1.14M)86K(3.49M)2.96M5.37M
Accounts Receivables(2.52M)7K(1.54M)(751K)(2.14M)
Inventory(291K)(536K)(2.43M)(1.4M)55.98K
Accounts Payables00007.45M
Other Working Capital1.67M615K479K5.11M0
Other Non-Cash Items(2.49M)(3.42M)(1.6M)(2.44M)12.7M
Operating Cash Flow(25.34M)(28.76M)(44.78M)(49.23M)(67.5M)
Capital Expenditures(11.82M)(16.35M)(10.96M)(6.07M)(804.7K)
Acquisitions (Net)00003K
Purchases of Investments0(102.62M)(80.02M)(97.83M)(42.03M)
Sales of Investments028.91M120.68M85.31M71.97M
Other Investing Activities(10.35M)(15.35M)(6.15M)(2.64M)0
Investing Cash Flow(11.82M)(89.95M)32.01M(16.33M)26.17M
Debt Repayment(863K)(1.07M)(1.24M)8.48M21.19M
Common Stock Issued77.73M255K18.34M69.72M20.86M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(393K)(167K)(243K)(758K)(3.26M)
Financing Cash Flow76.47M(983K)16.86M77.44M38.79M
Effect of Forex Changes3.89M2.06M(369K)688K2.41M
Net Change in Cash43.21M(117.62M)3.72M12.58M(130.69K)
Free Cash Flow(37.15M)(45.11M)(55.74M)(55.3M)(68.3M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$90.1M
+ D&A$4.5M
+ Stock-Based Comp$0
+ Deferred Tax$0
+ Working Capital$5.4M
+ Other Non-Cash$12.7M
= Operating Cash Flow-$67.5M
- Capex-$804.7K
= Free Cash Flow-$68.3M

Analysis

FY2025 free cash flow is -$68.3M. FCF conversion is 75.8% of net income. Operating cash flow was -$67.5M, with capex of -$804.7K. The largest bridge item is Other Non-Cash at $12.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
6-K6-K filingOct 20, 2026
6-K6-K filingSep 29, 2026
6-K6-K filingSep 22, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

Does NYXH generate free cash flow?

Nyxoah S.A. (NYXH) generated -$68.30M of free cash flow in fiscal 2025.

How much operating cash flow does NYXH produce?

Operating cash flow was -$67.50M, before capital expenditures of $804,698.00.